+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Radiopharmaceuticals Market 2025-2029

  • PDF Icon

    Report

  • 214 Pages
  • February 2025
  • Region: Global
  • TechNavio
  • ID: 5118661
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The radiopharmaceuticals market is forecasted to grow by USD 7.02 billion during 2024-2029, accelerating at a CAGR of 12.3% during the forecast period. The report on the radiopharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence of neurological disorders, growing cancer cases and rising investment in oncology market, and minimal side effects of radiopharmaceuticals.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The radiopharmaceuticals market is segmented as below:

By Source

  • Cyclotrons
  • Nuclear reactors

By End-user

  • Diagnostics
  • Therapeutics

By Application

  • Oncology
  • Cardiology
  • Neurology

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the production of cyclotron-based radiopharmaceuticals as one of the prime reasons driving the radiopharmaceuticals market growth during the next few years. Also, discovery and development of new radiopharmaceuticals and improvement in healthcare infrastructure in emerging economies will lead to sizable demand in the market.

The report on the radiopharmaceuticals market covers the following areas:

  • Radiopharmaceuticals Market sizing
  • Radiopharmaceuticals Market forecast
  • Radiopharmaceuticals Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading radiopharmaceuticals market vendors that include Bayer AG, Bracco Spa, Cardinal Health Inc., Curium Pharma, Eckert and Ziegler AG, GE Healthcare Technologies Inc., IBA Radiopharma Solutions, Jubilant Draximage Radiopharmacies Inc., Lantheus, Mallinckrodt PLC, NorthStar Medical Radioisotopes LLC, Novartis AG, NTP Radioisotopes SOC Ltd., PharmaLogic Holdings Corp., Positron Corp., Radiomedix Inc., Siemens AG, Sinotau Pharmaceuticals, Sotera Health Co., and Telix Pharmaceuticals Ltd. Also, the radiopharmaceuticals market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Source
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Radiopharmaceuticals Market 2019 - 2023
Historic Market Size - Data Table on Global Radiopharmaceuticals Market 2019 - 2023 ($ million)
5.2 Source segment analysis 2019 - 2023
Historic Market Size - Source Segment 2019 - 2023 ($ million)
5.3 End-user segment analysis 2019 - 2023
Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.4 Application segment analysis 2019 - 2023
Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 AI Impact on Global Radiopharmaceuticals Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Source
8.1 Market segments
Chart on Source - Market share 2024-2029 (%)
Data Table on Source - Market share 2024-2029 (%)
8.2 Comparison by Source
Chart on Comparison by Source
Data Table on Comparison by Source
8.3 Cyclotrons - Market size and forecast 2024-2029
Chart on Cyclotrons - Market size and forecast 2024-2029 ($ million)
Data Table on Cyclotrons - Market size and forecast 2024-2029 ($ million)
Chart on Cyclotrons - Year-over-year growth 2024-2029 (%)
Data Table on Cyclotrons - Year-over-year growth 2024-2029 (%)
8.4 Nuclear reactors - Market size and forecast 2024-2029
Chart on Nuclear reactors - Market size and forecast 2024-2029 ($ million)
Data Table on Nuclear reactors - Market size and forecast 2024-2029 ($ million)
Chart on Nuclear reactors - Year-over-year growth 2024-2029 (%)
Data Table on Nuclear reactors - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Source
Market opportunity by Source ($ million)
Data Table on Market opportunity by Source ($ million)
9 Market Segmentation by End-user
9.1 Market segments
Chart on End-user - Market share 2024-2029 (%)
Data Table on End-user - Market share 2024-2029 (%)
9.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
9.3 Diagnostics - Market size and forecast 2024-2029
Chart on Diagnostics - Market size and forecast 2024-2029 ($ million)
Data Table on Diagnostics - Market size and forecast 2024-2029 ($ million)
Chart on Diagnostics - Year-over-year growth 2024-2029 (%)
Data Table on Diagnostics - Year-over-year growth 2024-2029 (%)
9.4 Therapeutics - Market size and forecast 2024-2029
Chart on Therapeutics - Market size and forecast 2024-2029 ($ million)
Data Table on Therapeutics - Market size and forecast 2024-2029 ($ million)
Chart on Therapeutics - Year-over-year growth 2024-2029 (%)
Data Table on Therapeutics - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
10 Market Segmentation by Application
10.1 Market segments
Chart on Application - Market share 2024-2029 (%)
Data Table on Application - Market share 2024-2029 (%)
10.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
10.3 Oncology - Market size and forecast 2024-2029
Chart on Oncology - Market size and forecast 2024-2029 ($ million)
Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
Chart on Oncology - Year-over-year growth 2024-2029 (%)
Data Table on Oncology - Year-over-year growth 2024-2029 (%)
10.4 Cardiology - Market size and forecast 2024-2029
Chart on Cardiology - Market size and forecast 2024-2029 ($ million)
Data Table on Cardiology - Market size and forecast 2024-2029 ($ million)
Chart on Cardiology - Year-over-year growth 2024-2029 (%)
Data Table on Cardiology - Year-over-year growth 2024-2029 (%)
10.5 Neurology - Market size and forecast 2024-2029
Chart on Neurology - Market size and forecast 2024-2029 ($ million)
Data Table on Neurology - Market size and forecast 2024-2029 ($ million)
Chart on Neurology - Year-over-year growth 2024-2029 (%)
Data Table on Neurology - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.9 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.10 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.11 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.12 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 Brazil - Market size and forecast 2024-2029
Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Chart on Brazil - Year-over-year growth 2024-2029 (%)
Data Table on Brazil - Year-over-year growth 2024-2029 (%)
12.15 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.16 UAE - Market size and forecast 2024-2029
Chart on UAE - Market size and forecast 2024-2029 ($ million)
Data Table on UAE - Market size and forecast 2024-2029 ($ million)
Chart on UAE - Year-over-year growth 2024-2029 (%)
Data Table on UAE - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
Companies covered
15.2 Company ranking index
Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
SWOT
15.5 Bracco Spa
Bracco Spa - Overview
Bracco Spa - Product / Service
Bracco Spa - Key offerings
SWOT
15.6 Cardinal Health Inc.
Cardinal Health Inc. - Overview
Cardinal Health Inc. - Business segments
Cardinal Health Inc. - Key news
Cardinal Health Inc. - Key offerings
Cardinal Health Inc. - Segment focus
SWOT
15.7 Curium Pharma
Curium Pharma - Overview
Curium Pharma - Product / Service
Curium Pharma - Key offerings
SWOT
15.8 Eckert and Ziegler AG
Eckert and Ziegler AG - Overview
Eckert and Ziegler AG - Business segments
Eckert and Ziegler AG - Key news
Eckert and Ziegler AG - Key offerings
Eckert and Ziegler AG - Segment focus
SWOT
15.9 GE Healthcare Technologies Inc.
GE Healthcare Technologies Inc. - Overview
GE Healthcare Technologies Inc. - Business segments
GE Healthcare Technologies Inc. - Key news
GE Healthcare Technologies Inc. - Key offerings
GE Healthcare Technologies Inc. - Segment focus
SWOT
15.10 IBA Radiopharma Solutions
IBA Radiopharma Solutions - Overview
IBA Radiopharma Solutions - Business segments
IBA Radiopharma Solutions - Key news
IBA Radiopharma Solutions - Key offerings
IBA Radiopharma Solutions - Segment focus
SWOT
15.11 Jubilant Draximage Radiopharmacies Inc.
Jubilant Draximage Radiopharmacies Inc. - Overview
Jubilant Draximage Radiopharmacies Inc. - Product / Service
Jubilant Draximage Radiopharmacies Inc. - Key offerings
SWOT
15.12 Lantheus
Lantheus - Overview
Lantheus - Business segments
Lantheus - Key offerings
Lantheus - Segment focus
SWOT
15.13 NorthStar Medical Radioisotopes LLC
NorthStar Medical Radioisotopes LLC - Overview
NorthStar Medical Radioisotopes LLC - Product / Service
NorthStar Medical Radioisotopes LLC - Key offerings
SWOT
15.14 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
15.15 NTP Radioisotopes SOC Ltd.
NTP Radioisotopes SOC Ltd. - Overview
NTP Radioisotopes SOC Ltd. - Product / Service
NTP Radioisotopes SOC Ltd. - Key offerings
SWOT
15.16 PharmaLogic Holdings Corp.
PharmaLogic Holdings Corp. - Overview
PharmaLogic Holdings Corp. - Product / Service
PharmaLogic Holdings Corp. - Key offerings
SWOT
15.17 Siemens AG
Siemens AG - Overview
Siemens AG - Business segments
Siemens AG - Key news
Siemens AG - Key offerings
Siemens AG - Segment focus
SWOT
15.18 Sotera Health Co.
Sotera Health Co. - Overview
Sotera Health Co. - Business segments
Sotera Health Co. - Key news
Sotera Health Co. - Key offerings
Sotera Health Co. - Segment focus
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
Research methodology
16.5 Data procurement
Information sources
16.6 Data validation
Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Source
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Market Segmentation by Application
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2024 and 2029
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value chain analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Historic Market Size - Data Table on Global Radiopharmaceuticals Market 2019 - 2023 ($ million)
Exhibits 26: Historic Market Size - Source Segment 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - Application Segment 2019 - 2023 ($ million)
Exhibits 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 31: Five forces analysis - Comparison between 2024 and 2029
Exhibits 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 37: Chart on Market condition - Five forces 2024 and 2029
Exhibits 38: Chart on Source - Market share 2024-2029 (%)
Exhibits 39: Data Table on Source - Market share 2024-2029 (%)
Exhibits 40: Chart on Comparison by Source
Exhibits 41: Data Table on Comparison by Source
Exhibits 42: Chart on Cyclotrons - Market size and forecast 2024-2029 ($ million)
Exhibits 43: Data Table on Cyclotrons - Market size and forecast 2024-2029 ($ million)
Exhibits 44: Chart on Cyclotrons - Year-over-year growth 2024-2029 (%)
Exhibits 45: Data Table on Cyclotrons - Year-over-year growth 2024-2029 (%)
Exhibits 46: Chart on Nuclear reactors - Market size and forecast 2024-2029 ($ million)
Exhibits 47: Data Table on Nuclear reactors - Market size and forecast 2024-2029 ($ million)
Exhibits 48: Chart on Nuclear reactors - Year-over-year growth 2024-2029 (%)
Exhibits 49: Data Table on Nuclear reactors - Year-over-year growth 2024-2029 (%)
Exhibits 50: Market opportunity by Source ($ million)
Exhibits 51: Data Table on Market opportunity by Source ($ million)
Exhibits 52: Chart on End-user - Market share 2024-2029 (%)
Exhibits 53: Data Table on End-user - Market share 2024-2029 (%)
Exhibits 54: Chart on Comparison by End-user
Exhibits 55: Data Table on Comparison by End-user
Exhibits 56: Chart on Diagnostics - Market size and forecast 2024-2029 ($ million)
Exhibits 57: Data Table on Diagnostics - Market size and forecast 2024-2029 ($ million)
Exhibits 58: Chart on Diagnostics - Year-over-year growth 2024-2029 (%)
Exhibits 59: Data Table on Diagnostics - Year-over-year growth 2024-2029 (%)
Exhibits 60: Chart on Therapeutics - Market size and forecast 2024-2029 ($ million)
Exhibits 61: Data Table on Therapeutics - Market size and forecast 2024-2029 ($ million)
Exhibits 62: Chart on Therapeutics - Year-over-year growth 2024-2029 (%)
Exhibits 63: Data Table on Therapeutics - Year-over-year growth 2024-2029 (%)
Exhibits 64: Market opportunity by End-user ($ million)
Exhibits 65: Data Table on Market opportunity by End-user ($ million)
Exhibits 66: Chart on Application - Market share 2024-2029 (%)
Exhibits 67: Data Table on Application - Market share 2024-2029 (%)
Exhibits 68: Chart on Comparison by Application
Exhibits 69: Data Table on Comparison by Application
Exhibits 70: Chart on Oncology - Market size and forecast 2024-2029 ($ million)
Exhibits 71: Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
Exhibits 72: Chart on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits 73: Data Table on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits 74: Chart on Cardiology - Market size and forecast 2024-2029 ($ million)
Exhibits 75: Data Table on Cardiology - Market size and forecast 2024-2029 ($ million)
Exhibits 76: Chart on Cardiology - Year-over-year growth 2024-2029 (%)
Exhibits 77: Data Table on Cardiology - Year-over-year growth 2024-2029 (%)
Exhibits 78: Chart on Neurology - Market size and forecast 2024-2029 ($ million)
Exhibits 79: Data Table on Neurology - Market size and forecast 2024-2029 ($ million)
Exhibits 80: Chart on Neurology - Year-over-year growth 2024-2029 (%)
Exhibits 81: Data Table on Neurology - Year-over-year growth 2024-2029 (%)
Exhibits 82: Market opportunity by Application ($ million)
Exhibits 83: Data Table on Market opportunity by Application ($ million)
Exhibits 84: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 85: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 86: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 87: Chart on Geographic comparison
Exhibits 88: Data Table on Geographic comparison
Exhibits 89: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 90: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 91: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 92: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 93: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 94: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 95: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 96: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 97: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 98: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 99: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 100: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 101: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 102: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 103: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 104: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 105: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 106: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 107: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 108: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 109: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 110: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 111: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 114: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 118: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 119: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 122: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits 138: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits 139: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on UAE - Market size and forecast 2024-2029 ($ million)
Exhibits 142: Data Table on UAE - Market size and forecast 2024-2029 ($ million)
Exhibits 143: Chart on UAE - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on UAE - Year-over-year growth 2024-2029 (%)
Exhibits 145: Market opportunity By Geographical Landscape ($ million)
Exhibits 146: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 147: Impact of drivers and challenges in 2024 and 2029
Exhibits 148: Overview on criticality of inputs and factors of differentiation
Exhibits 149: Overview on factors of disruption
Exhibits 150: Impact of key risks on business
Exhibits 151: Companies covered
Exhibits 152: Company ranking index
Exhibits 153: Matrix on companies position and classification
Exhibits 154: Bayer AG - Overview
Exhibits 155: Bayer AG - Business segments
Exhibits 156: Bayer AG - Key news
Exhibits 157: Bayer AG - Key offerings
Exhibits 158: Bayer AG - Segment focus
Exhibits 159: SWOT
Exhibits 160: Bracco Spa - Overview
Exhibits 161: Bracco Spa - Product / Service
Exhibits 162: Bracco Spa - Key offerings
Exhibits 163: SWOT
Exhibits 164: Cardinal Health Inc. - Overview
Exhibits 165: Cardinal Health Inc. - Business segments
Exhibits 166: Cardinal Health Inc. - Key news
Exhibits 167: Cardinal Health Inc. - Key offerings
Exhibits 168: Cardinal Health Inc. - Segment focus
Exhibits 169: SWOT
Exhibits 170: Curium Pharma - Overview
Exhibits 171: Curium Pharma - Product / Service
Exhibits 172: Curium Pharma - Key offerings
Exhibits 173: SWOT
Exhibits 174: Eckert and Ziegler AG - Overview
Exhibits 175: Eckert and Ziegler AG - Business segments
Exhibits 176: Eckert and Ziegler AG - Key news
Exhibits 177: Eckert and Ziegler AG - Key offerings
Exhibits 178: Eckert and Ziegler AG - Segment focus
Exhibits 179: SWOT
Exhibits 180: GE Healthcare Technologies Inc. - Overview
Exhibits 181: GE Healthcare Technologies Inc. - Business segments
Exhibits 182: GE Healthcare Technologies Inc. - Key news
Exhibits 183: GE Healthcare Technologies Inc. - Key offerings
Exhibits 184: GE Healthcare Technologies Inc. - Segment focus
Exhibits 185: SWOT
Exhibits 186: IBA Radiopharma Solutions - Overview
Exhibits 187: IBA Radiopharma Solutions - Business segments
Exhibits 188: IBA Radiopharma Solutions - Key news
Exhibits 189: IBA Radiopharma Solutions - Key offerings
Exhibits 190: IBA Radiopharma Solutions - Segment focus
Exhibits 191: SWOT
Exhibits 192: Jubilant Draximage Radiopharmacies Inc. - Overview
Exhibits 193: Jubilant Draximage Radiopharmacies Inc. - Product / Service
Exhibits 194: Jubilant Draximage Radiopharmacies Inc. - Key offerings
Exhibits 195: SWOT
Exhibits 196: Lantheus - Overview
Exhibits 197: Lantheus - Business segments
Exhibits 198: Lantheus - Key offerings
Exhibits 199: Lantheus - Segment focus
Exhibits 200: SWOT
Exhibits 201: NorthStar Medical Radioisotopes LLC - Overview
Exhibits 202: NorthStar Medical Radioisotopes LLC - Product / Service
Exhibits 203: NorthStar Medical Radioisotopes LLC - Key offerings
Exhibits 204: SWOT
Exhibits 205: Novartis AG - Overview
Exhibits 206: Novartis AG - Business segments
Exhibits 207: Novartis AG - Key news
Exhibits 208: Novartis AG - Key offerings
Exhibits 209: Novartis AG - Segment focus
Exhibits 210: SWOT
Exhibits 211: NTP Radioisotopes SOC Ltd. - Overview
Exhibits 212: NTP Radioisotopes SOC Ltd. - Product / Service
Exhibits 213: NTP Radioisotopes SOC Ltd. - Key offerings
Exhibits 214: SWOT
Exhibits 215: PharmaLogic Holdings Corp. - Overview
Exhibits 216: PharmaLogic Holdings Corp. - Product / Service
Exhibits 217: PharmaLogic Holdings Corp. - Key offerings
Exhibits 218: SWOT
Exhibits 219: Siemens AG - Overview
Exhibits 220: Siemens AG - Business segments
Exhibits 221: Siemens AG - Key news
Exhibits 222: Siemens AG - Key offerings
Exhibits 223: Siemens AG - Segment focus
Exhibits 224: SWOT
Exhibits 225: Sotera Health Co. - Overview
Exhibits 226: Sotera Health Co. - Business segments
Exhibits 227: Sotera Health Co. - Key news
Exhibits 228: Sotera Health Co. - Key offerings
Exhibits 229: Sotera Health Co. - Segment focus
Exhibits 230: SWOT
Exhibits 231: Inclusions checklist
Exhibits 232: Exclusions checklist
Exhibits 233: Currency conversion rates for US$
Exhibits 234: Research methodology
Exhibits 235: Information sources
Exhibits 236: Data validation
Exhibits 237: Validation techniques employed for market sizing
Exhibits 238: Data synthesis
Exhibits 239: 360 degree market analysis
Exhibits 240: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global radiopharmaceuticals market: Bayer AG, Bracco Spa, Cardinal Health Inc., Curium Pharma, Eckert and Ziegler AG, GE Healthcare Technologies Inc., IBA Radiopharma Solutions, Jubilant Draximage Radiopharmacies Inc., Lantheus, Mallinckrodt Plc, NorthStar Medical Radioisotopes LLC, Novartis AG, NTP Radioisotopes SOC Ltd., PharmaLogic Holdings Corp., Positron Corp., Radiomedix Inc., Siemens AG, Sinotau Pharmaceuticals, Sotera Health Co., and Telix Pharmaceuticals Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is production of cyclotron-based radiopharmaceuticals."

According to the report, one of the major drivers for this market is the rising incidence of neurological disorders.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Bayer AG
  • Bracco Spa
  • Cardinal Health Inc.
  • Curium Pharma
  • Eckert and Ziegler AG
  • GE Healthcare Technologies Inc.
  • IBA Radiopharma Solutions
  • Jubilant Draximage Radiopharmacies Inc.
  • Lantheus
  • Mallinckrodt Plc
  • NorthStar Medical Radioisotopes LLC
  • Novartis AG
  • NTP Radioisotopes SOC Ltd.
  • PharmaLogic Holdings Corp.
  • Positron Corp.
  • Radiomedix Inc.
  • Siemens AG
  • Sinotau Pharmaceuticals
  • Sotera Health Co.
  • Telix Pharmaceuticals Ltd.

Related Topics

Related Reports

Radiopharmaceutical Theranostics Market Report 2025 - Product Image

Radiopharmaceutical Theranostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Radiopharmaceuticals: Technologies and Global Markets - Product Image

Radiopharmaceuticals: Technologies and Global Markets

  • Report
  • 163 Pages
  • Global
From
Nuclear Medicine/Radiopharmaceuticals - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Nuclear Medicine/Radiopharmaceuticals - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Radiopharmaceuticals Market - Products and Applications - Product Image

Radiopharmaceuticals Market - Products and Applications

  • Report
  • 307 Pages
  • Global
From
Radiopharmaceuticals Market Report 2025 - Product Image

Radiopharmaceuticals Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.